Cervical cancer prevention in HIV infected women in Pune, India
Not Applicable
Completed
- Conditions
- Health Condition 1: null- HIV-infected women
- Registration Number
- CTRI/2013/11/004132
- Lead Sponsor
- Prayas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1153
Inclusion Criteria
1. HIV-infected women
2. Willing to sign an informed consent form
3. Having an intact uterus
Exclusion Criteria
1. Women who have undergone hysterectomy
2. Women having a debilitating health condition
3. Women with prior history of any procedure on the cervix
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Test performance of cytology, VIA, VILI and HPV testing to detect CIN 2-3 lesions <br/ ><br>2. Prevalence and type distribution of high-risk HPV types in HIV-infected women and its correlation with cervical abnormalities <br/ ><br>3. Distribution of HPV types in CIN and in cervical cancer specimens in HIV-infected <br/ ><br>Timepoint: Baseline at screening
- Secondary Outcome Measures
Name Time Method Effectiveness of cold coagulation in curing and preventing recurrence of CIN 2-3 lesions in HIV-infected womenTimepoint: Initially after 6 months and then every year thereafter